Anti-Proteasome 20S C2/HC2 antibody
5
(2 Reviews)
|
(39 Publications)
Rabbit Polyclonal PSA1 antibody. Suitable for WB, IHC-P, ICC/IF and reacts with Chinese hamster, Human, Mouse, Rat, Hamster, Dog samples. Cited in 39 publications. Immunogen corresponding to Synthetic Peptide within Human PSMA1 aa 200 to C-terminus.
View Alternative Names
HC2, NU, PROS30, PSC2, PSMA1, Proteasome subunit alpha type-1, 30 kDa prosomal protein, Macropain subunit C2, Multicatalytic endopeptidase complex subunit C2, Proteasome component C2, Proteasome nu chain, Proteasome subunit alpha-6, PROS-30, alpha-6
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-Proteasome 20S C2/HC2 antibody (AB3325)
Immunofluorescence analysis of 70% confluent log phase MDA-MB-231 (Human breast adenocarcinoma cell line) cells labeling Proteasome 20S C2/HC2 (green) with ab3325 at 2 μg/mL. The cells were fixed with 4% paraformaldehyde for 10 minutes, permeabilized with 0.1% Triton™ X-100 for 10 minutes, and blocked with 1% BSA for 1 hour at room temperature. The cells were labeled with ab3325 in 0.1% BSA and incubated for 3 hours at room temperature and then labeled with Goat anti-Rabbit IgG (H+L) secondary antibody, Alexa Fluor® 488 conjugate at 1/2000 dilution for 45 minutes at room temperature (Panel a : green). Nuclei (Panel b : blue) were stained with DAPI. F-actin (Panel c : red) was stained with Alexa Fluor® 555 Rhodamine Phalloidin. Panel d represents the merged image showing cytoplasmic localization. Panel e shows the control without primary antibody. The images were captured at 60X magnification.
- WB
Supplier Data
Western blot - Anti-Proteasome 20S C2/HC2 antibody (AB3325)
Known quantity of protein samples were electrophoresed using Novex® NuPAGE® 4-12 % Bis-Tris gel, XCell SureLock™ Electrophoresis System and Novex® Sharp Pre-Stained Protein Standard. Resolved proteins were then transferred onto a nitrocellulose membrane with iBlot® 2 Dry Blotting System. The membrane was probed with the relevant primary and secondary Antibody following blocking with 5% skimmed milk. Chemiluminescent detection was performed using Pierce™ ECL Western Blotting Substrate.
All lanes:
Western blot - Anti-Proteasome 20S C2/HC2 antibody (ab3325) at 2 µg/mL
Lane 1:
MDA-MB-231 (Human breast adenocarcinoma cell line) whole cell lysate at 30 µg
Lane 2:
MCF7 (Human breast adenocarcinoma cell line) whole cell lysate at 30 µg
Lane 3:
PC-3 (Human prostate adenocarcinoma cell line) whole cell lysate at 30 µg
Lane 4:
HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate at 30 µg
Lane 5:
Jurkat (Human T cell leukemia cell line from peripheral blood) whole cell lysate at 30 µg
Secondary
All lanes:
Goat anti-Rabbit IgG (H+L) HRP cpnjugate at 0.4 µg/mL
Predicted band size: 30 kDa
true
- WB
Unknown
Western blot - Anti-Proteasome 20S C2/HC2 antibody (AB3325)
All lanes:
Western blot - Anti-Proteasome 20S C2/HC2 antibody (ab3325) at 3 µg/mL
All lanes:
CHO (Chinese hamster ovary cell line) whole cell lysate
Predicted band size: 30 kDa
false
- WB
Supplier Data
Western blot - Anti-Proteasome 20S C2/HC2 antibody (AB3325)
All lanes:
Western blot - Anti-Proteasome 20S C2/HC2 antibody (ab3325) at 2 µg/mL
Lane 1:
Untransfected Hep G2 whole cell extract.
Lane 2:
Proteasome 20S C2/HC2 non-targeting scrambled siRNA transfected Hep G2 whole cell extract.
Lane 3:
Proteasome 20S C2/HC2 knockdown Hep G2 whole cell extract.
Secondary
All lanes:
Goat anti-Rabbit IgG (H+L) Superclonal™ Recombinant Secondary Antibody, HRP at 1/4000 dilution
Predicted band size: 30 kDa
Observed band size: 45 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Proteasome 20S C2/HC2 plays a significant role in maintaining protein quality by participating in proteolytic degradation. It forms part of the larger 26S proteasome complex which assembles with regulatory particles for substrate recognition. This protein is essential for the breakdown and removal of oxidized or misfolded proteins thereby preventing the accumulation of potentially toxic aggregates within the cell. It ensures cellular regulation by processing proteins that control various aspects of cell cycle signaling and differentiation.
Pathways
The activity of the Proteasome 20S C2/HC2 integrates directly into the ubiquitin-proteasome pathway. This pathway regulates protein turnover and plays a vital role in cellular processes such as the cell cycle and apoptosis. The association with proteins such as ubiquitin and E3 ligases is critical for the marking of substrate proteins for degradation. This protein is also linked to the NF-kB signaling pathway interacting with proteins that modulate immune and inflammatory responses demonstrating its influence on broader regulatory networks.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (39)
Recent publications for all applications. Explore the full list and refine your search
American journal of physiology. Renal physiology 326:F814-F826 PubMed38545647
2024
Applications
Unspecified application
Species
Unspecified reactive species
Communications biology 6:1127 PubMed37935829
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:4092 PubMed37433777
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature aging 3:546-566 PubMed37118550
2023
Applications
Unspecified application
Species
Unspecified reactive species
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36:e22583 PubMed36197017
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in physiology 13:971251 PubMed36160843
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in molecular neuroscience 15:861873 PubMed35531068
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cells 11: PubMed35011657
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular physiology 236:5012-5021 PubMed33400289
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cancer chemotherapy and pharmacology 85:843-853 PubMed32232513
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com